Neuroprotection Devices in Cardiac Catheterization Laboratories: Does It Sufficiently Protect Our Patients?
Clement Tan,
No information about this author
Mark Higgins,
No information about this author
Vaikunthan Thanabalasingam
No information about this author
et al.
Medicina,
Journal Year:
2025,
Volume and Issue:
61(2), P. 305 - 305
Published: Feb. 10, 2025
Stroke
is
a
devastating
complication
of
cardiovascular
interventions.
Intraprocedural
stroke
well-documented
and
feared
risk
cardiac
percutaneous
transcatheter
procedures.
If
clinically
significant
strokes
are
absent,
silent
remain
the
next
in
line
to
pose
large
concerns
related
future
cognitive
decline,
risk,
overall
increased
morbidity
mortality.
Cerebral
protection
devices
(CPD)
developed
overtime
aim
neutralize
this
through
either
capture-based
filter
or
deflector
mechanism.
Many
CPDs
exist
currently,
each
one
unique,
with
varying
degrees
evidence.
The
adoption
has
allowed
procedures
be
carried
out
patients
high
thromboembolic
risks
who
may
have
historically
been
discommended.
Though
skewed
towards
certain
procedures,
body
evidence
still
present
across
other
This
review
will
discuss
clinical
importance
respective
rates,
updated
surrounding
CPDs,
differing
opinions
types
cost
benefits,
what
lies
ahead
for
within
realm
undertaken
catheterization
laboratories.
Language: Английский
Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Implantation: Meta‐Analysis With Trial Sequential Analysis
Journal of the American Heart Association,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 21, 2025
Background
We
aimed
to
reevaluate
randomized
controlled
trial
data
on
outcomes
of
cerebral
embolic
protection
device
use
during
transcatheter
aortic
valve
implantation.
A
conventional
meta‐analysis
followed
by
sequential
analysis
was
conducted
evaluate
the
strength
current
evidence.
Methods
and
Results
Databases
were
searched
for
trials.
Primary
included
all
stroke,
disabling
all‐cause
mortality.
Conventional
study‐level
performed
using
random‐effects
modeling.
Trial
generate
adjusted
significance
boundaries,
futility
required
information
size
considering
a
type
I
error
5%
power
90%.
Seven
trials
with
total
4031
patients,
whom
2171
treated
1860
not.
showed
no
significant
difference
in
stroke
(relative
risk
[RR],
0.85
[95%
CI,
0.61–1.18];
P
=0.339)
(RR,
0.59
0.30–1.13];
=0.113)
use.
The
determined
an
absence
evidence
(required
71
650
[5.6%])
337
256
[1.2%]).
mortality
1.03
0.49–2.17];
=0.928)
that
boundary
reached
5772
[69.3%]).
Conclusions
There
are
insufficient
provide
conclusive
meta‐analytic
findings
outcomes.
Language: Английский
A Systematic Review of Transcarotid Approach for Endovascular Aortic Repair in Treating Aortic Disease
Haofan Shi,
No information about this author
Xinrui Guo,
No information about this author
Chengkai Su
No information about this author
et al.
Vascular and Endovascular Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 25, 2025
Purpose
The
purpose
of
this
study
is
to
evaluate
the
feasibility,
efficacy,
and
safety
transcarotid
approach
endovascular
aortic
repair
(EVAR)
in
patients
where
conventional
femoral
access
not
possible.
Materials
Methods
A
systematic
review
all
articles
discussing
EVAR
published
PubMed,
Embase,
Ovid,
Web
Science,
Cochrane
Library
databases
were
conducted.
This
was
conducted
accordance
with
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
guidelines.
Results
In
inclusion
criteria,
17
retrieved,
encompassing
18
patients.
Among
these
patients,
6
related
ascending
disease,
including
4
cases
pseudoaneurysms,
1
case
penetrating
ulcer,
dissection.
9
had
descending
comprising
aneurysms,
2
ulcers,
pseudoaneurysm.
There
3
abdominal
aneurysms
endoleak.
10
through
left
common
carotid
artery,
8
right
artery.
One
patient
experienced
spinal
cord
ischemia
subsequently
died
multi-organ
failure
caused
by
acute
pancreatitis.
Additionally,
there
one
minor
embolization
nonsurgical
supply
area.
No
cerebral
infarctions
observed
vascular
territory
ipsilateral
artery
at
surgical
site.
Conclusions
Research
on
limited
predominantly
consists
reports,
a
notable
absence
randomized
controlled
trials.
suggests
that
may
be
viable
alternative
selecting
groups
when
feasible.
These
findings
indicate
method
associated
relatively
manageable
perioperative
complications
mortality
rates.
Language: Английский
Transcarotid Artery Approach for Endovascular Aortic Repair in Treating Complex Descending Thoracic Aortic Pseudoaneurysm With Aortoiliac Occlusion: A Case Report
Haofan Shi,
No information about this author
Xinrui Guo,
No information about this author
Chengkai Su
No information about this author
et al.
Vascular and Endovascular Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 10, 2025
Background
Endovascular
aortic
repair
has
emerged
as
the
preferred
treatment
modality
over
open
surgery
for
diseases,
primarily
because
of
its
association
with
lower
perioperative
morbidity
and
mortality
rates.
Current
diagnostic
guidelines
generally
advocate
endovascular
in
most
cases,
femoral
artery
serving
conventional
access
route.
However,
this
approach
may
not
be
feasible
all
patients,
particularly
those
aortoiliac
occlusion,
necessitating
alternative
strategies.
Case
Summary
This
paper
presents
a
complex
case
study
patient
occlusion
who
underwent
via
left
carotid
pseudoaneurysm
at
anastomotic
site
descending
prosthetic
graft.
underscores
potential
value
utilizing
an
route
anatomically
challenging
situations.
Conclusion
Research
on
transcarotid
is
limited
predominantly
consists
reports,
notable
absence
randomized
controlled
trials.
report
suggests
that
viable
selecting
groups
when
feasible.
While
our
single
demonstrated
successful
management
minimal
complications,
larger
studies
are
needed
to
fully
establish
safety
profile
determine
if
complications
rates
indeed
manageable
across
diverse
populations.
Clinical
Impact
provides
valuable
insights
into
feasibility
patients
occlusion.
It
offers
clinicians
strategy
cases
where
The
findings
presented
herein
aim
demonstrate
practicality
relative
procedures
scenarios,
contributing
broader
understanding
alternatives
interventions.
Language: Английский
Meta-Analysis on Comparison of Fasting Versus No Fasting Before Cardiac Catheterization
Jawad Basit,
No information about this author
Mushood Ahmed,
No information about this author
Muhammad Burhan
No information about this author
et al.
Cardiology in Review,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Patients
undergoing
cardiac
catheterization
are
advised
not
to
take
anything
by
mouth
after
midnight.
However,
limited
scientific
data
exist
on
whether
fasting
before
procedures
improves
clinical
outcomes
compared
with
nonfasting.
A
comprehensive
literature
search
was
performed
investigators
using
major
bibliographic
databases
identify
studies
that
for
versus
nonfasting
patient
groups
following
procedures.
The
risk
ratios
(RR)
and
mean
difference
(MD)
were
pooled
along
95%
confidence
intervals
(CIs)
dichotomous
continuous
R
studios.
total
of
9
trials
included
in
the
review
reporting
3432
patients
(fasting:
1710
nonfasting:
1702).
There
no
statistically
significant
between
2
incidence
procedural
complications
(RR:
1.05,
CI:
0.78–1.40;
P
=
0.757),
30-day
mortality
0.83,
0.32–2.18;
0.71),
readmissions
0.74–1.49;
0.77),
aspiration
0.45,
0.06–3.50;
0.45),
contrast-associated
acute
kidney
injury
0.90,
0.52–1.58;
p
0.72),
hypoglycemia
1.27,
0.74–2.17;
0.39),
nausea/vomiting
0.46–1.51;
0.55).
group
associated
significantly
better
satisfaction
scores
(standardized
MD:
0.70,
0.13–1.27;
0.02).
Before
catheterization,
a
approach
is
higher
similar
adverse
events
approach.
practice
routine
should
be
reconsidered.
Language: Английский